Unveiling Culprits, Part 2: The Hypnagogic Jab

Cracked Science

As I write this, British multinational pharmaceutical company GlaxoSmithKline is conducting a study in my backyard.

No, there are no lab-coat-clad scientists bagging petunias in my garden. I don’t have a garden, much less a backyard. (And, for what it’s worth, I think “Bagging Petunias” would be an awesome band name)

By backyard, I mean the Province of Quebec, an admittedly large yard by anyone’s standards: 1.5 million km2 (almost 600,000 mi2) in total area. But this is where GlaxoSmithKline is conducting its retrospective cohort study, with preliminary results to be revealed in “early 2014”1. What are they studying? Whether or not their H1N1 flu vaccine Arepanrix, which was administered to Quebecers during the 2009-2010 H1N1 pandemic, was associated with a higher incidence of narcolepsy.

A retrospective cohort study is when a research group looks at the medical files of groups of individuals who are…

View original post 1,760 more words

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s